期刊
PHYTOTHERAPY RESEARCH
卷 35, 期 4, 页码 2200-2210出版社
WILEY
DOI: 10.1002/ptr.6971
关键词
cellular bioenergetics; chlorogenic acid; c‐ Myc; iron metabolism; pancreatic carcinoma
资金
- National Natural Science Foundation Youth Fund Project [81902803]
- Science and Technology Bureau of Wenzhou [Y20190069]
Pancreatic ductal adenocarcinoma (PDAC) is a severe malignant tumor in human, and chlorogenic Acid (CA) has been found to suppress PDAC cell growth by targeting the c-Myc-TFR1 axis, indicating its potential as a promising compound for PDAC treatment.
Pancreatic ductal adenocarcinoma (PDAC) is severe malignant tumor in human, the outcomes of PDAC is extremely poor. Here, we evaluated the potential anti-tumor activity of chlorogenic Acid (CA) in PDAC. Here, we found CA was effective to suppress PDAC cell growth in vitro and in vivo. Importantly, we found overall oxygen consumption rate was significantly decreased in CA dose-dependent manner. We also found glycolysis reverse was decreased in CA-treated cells, while basal glycolysis and glycolytic capacity were not significantly changed. Mechanistically, we demonstrated TFR1 could be a novel downstream target of CA, which is essential for PDAC cell growth and cellular bioenergetics maintenance. Furthermore, we validated that CA-reduced c-Myc resulted to down-regulation of TFR1, which contributes to mitochondrial respiration dysfunction and cell growth delay. Together, this study indicates that CA suppresses PDAC cell growth through targeting c-Myc-TFR1 axis and suggests CA could be considered as a promising compound for PDAC treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据